If You Invested in Dogecoin Cash (CBDS)
Looking for the current price? See the CBDS quote & overviewWhat $1,000 or $10,000 in CBDS Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jul 31, 2015 |
|---|---|---|---|---|
| $1,000 | — | $69 -93% | $15 -98% | $14 -99% |
| $10,000 | — | $690 -93% | $151 -98% | $143 -99% |
Based on real historical closing prices, dividend- and split-adjusted, through 2025-06-09. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CBDS$1,000 Investment Over Time
CBDS vs S&P 500Year-by-Year Returns
CBDS annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2016 | $0.69 | $5.40 | +682.6% | +682.6% |
| 2017 | $5.73 | $6.42 | +12.0% | +830.4% |
| 2018 | $7.47 | $2.73 | -63.5% | +295.7% |
| 2019 | $3.05 | $0.54 | -82.3% | -21.7% |
| 2020 | $0.57 | $0.48 | -15.8% | -30.4% |
| 2021 | $0.51 | $0.1778 | -65.1% | -74.2% |
| 2022 | $0.1998 | $0.0360 | -82.0% | -94.8% |
| 2023 | $0.0360 | $0.0090 | -75.0% | -98.7% |
| 2024 | $0.0090 | $0.0870 | +866.7% | -87.4% |
| 2025 | $0.0878 | $0.0276 | -68.6% | -96.0% |
About Dogecoin Cash
Manufacturing · OTC
Dogecoin Cash Inc. (OTCQB: CBDS) is a publicly traded company that combines medical cannabis telemedicine, cannabis product development and licensing, and blockchain-focused digital asset initiatives. According to company disclosures, Dogecoin Cash Inc. owns and operates PrestoDoctor, a telehealth platform for medical cannabis evaluations, and holds intellectual property related to cannabis, including the first patented cannabis strain known as Ecuadorian Sativa ("CTA") and a patented cannabis lozenge for the treatment of hypertension.
The company is associated with the manufacturing sector and has been described in industry classifications as operating within all other miscellaneous chemical product and preparation manufacturing. Its activities span cannabis-related wellness and pharmaceutical-oriented formulations, as well as technology efforts connected to blockchain and digital assets.
Business Focus and Segments
Dogecoin Cash Inc. reports several core areas of operation:
- Medical cannabis telemedicine: Through its subsidiary PrestoDoctor, the company facilitates online consultations for medical cannabis evaluations. PrestoDoctor uses a secure, HIPAA-compliant telehealth platform and connects patients with licensed clinicians who are authorized to recommend medical cannabis in multiple U.S. states.
- Cannabis product development and licensing: Company disclosures state that Dogecoin Cash Inc. engages in cannabis product development and licensing activities, including CBD-infused wellness products, consumer goods, and pharmaceutical-grade formulations, as well as patented cannabis genetics and dosage forms such as its cannabis lozenge.
- Blockchain and digital asset initiatives: The company focuses on blockchain innovation, digital asset strategies, and related infrastructure, including activities around Dogecoin and meme-based tokens held through subsidiaries.
PrestoDoctor Telehealth Platform
PrestoDoctor is described as a trusted leader in medical cannabis telemedicine. Company materials explain that the platform provides secure online appointments with licensed physicians and other qualified clinicians for medical cannabis evaluations and certifications. PrestoDoctor operates in multiple U.S. states and emphasizes compliance with applicable medical cannabis and telemedicine regulations in each jurisdiction where it is active.
The platform is characterized as HIPAA-compliant and designed specifically for medical cannabis telehealth, with features that include secure video consultations, encrypted patient records, real-time physician scheduling, and digital delivery of recommendations. According to the company, this proprietary telemedicine system was developed in-house and is tailored to the requirements of regulated healthcare and cannabis programs.
Cannabis Intellectual Property and Product Development
Dogecoin Cash Inc. reports that it holds the first patented cannabis strain, Ecuadorian Sativa ("CTA"), as well as a patented cannabis lozenge for treatment of hypertension. These patents form part of its cannabis product development and licensing strategy. The company further indicates that it is involved in developing and commercializing cannabis-based products, including CBD-infused wellness solutions, consumer products, and pharmaceutical-grade formulations, and that it seeks to expand its product portfolio through licensing agreements, research partnerships, and acquisitions in the cannabis industry.
Blockchain Innovation and Digital Asset Strategy
Beyond cannabis, Dogecoin Cash Inc. emphasizes its engagement with blockchain technology and digital assets. Company descriptions state that it explores applications in tokenization, smart contracts, decentralized finance (DeFi) protocols, and blockchain-based infrastructure. The business is described as actively engaged in leveraging emerging digital assets and blockchain technology to enhance its offerings and pursue new market opportunities.
Through its subsidiary MEME Coins Inc., the company holds DOG tokens as a digital asset and characterizes MEME Coins Inc. as an emerging platform focused on meme-based cryptocurrency innovation, token utility, and social crypto applications. Dogecoin Cash Inc. also reports the formation of Dogecoin Treasury, Inc. (DTI), a wholly owned subsidiary established to support development and management of software tools and infrastructure related to Dogecoin, including work on a proposed Dogecoin Protocol framework.
Dogecoin Protocol and Digital Infrastructure
Company news releases describe a proposed Dogecoin Protocol, a modular, blockchain-agnostic application architecture intended to support integration of Dogecoin into decentralized applications. The company has reported preparation and filing of a U.S. provisional patent application covering this framework, which is intended to enable decentralized applications that incorporate Dogecoin transaction capabilities and interact with both UTXO-based blockchains and smart contract platforms.
Dogecoin Treasury, Inc. is expected to manage related intellectual property, technology planning, and digital assets associated with these initiatives. The company has outlined potential components under evaluation, such as a chain-connect layer, low-code tools, and deployment utilities, all oriented toward Dogecoin-related development and interoperability.
Strategic Growth and Market Positioning
In its own descriptions, Dogecoin Cash Inc. states that it pursues acquisitions, partnerships, and joint ventures in both the cannabis and blockchain arenas. It highlights an intention to expand market penetration and diversify revenue streams through cannabis telemedicine, cannabis product development and licensing, and blockchain-based initiatives.
The company also notes a focus on regulatory compliance in cannabis and healthcare, while exploring ways to apply blockchain and DeFi concepts to areas such as traceability in the cannabis industry, digital payment integrations, and other real-world applications. This combination of medical cannabis telehealth, patented cannabis products, and blockchain-related projects is presented as the core of Dogecoin Cash Inc.’s business model.
Relationship to the CBDS Ticker
Dogecoin Cash Inc. is identified in company materials as trading on the OTCQB market under the symbol CBDS. Earlier descriptions of the CBDS symbol referenced Cannabis Sativa, Inc. and subsidiaries engaged in herbal-based skin care products and cannabis formulations. Current company disclosures, however, describe Dogecoin Cash Inc. as the public company associated with CBDS, with operations centered on PrestoDoctor’s medical cannabis telemedicine services, cannabis intellectual property, and blockchain-focused initiatives. Users researching the CBDS ticker should refer to Dogecoin Cash Inc. for the latest company profile and disclosures.
Frequently Asked Questions
Dogecoin Cash investment returns
How much would $1,000 invested in Dogecoin Cash be worth today?
If you invested $1,000 in Dogecoin Cash (CBDS) 10 years ago on 2016-08-01, your investment would be worth $15 as of 2025-06-09, representing a -98.5% total return, growing at a compounded rate of -37.7% per year (CAGR).
Has Dogecoin Cash outperformed the S&P 500?
Over the past 10 years, CBDS returned -98.5% compared to +285.6% for the S&P 500, underperforming the benchmark by 384.1 percentage points.
What is Dogecoin Cash's average annual return?
The compound annual growth rate (CAGR) of CBDS over the past 10 years is -37.7%, growing at a compounded rate each year. Individual years vary significantly — CBDS's best recent year was 2024 (+866.7%) and worst was 2019 (-82.3%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
